Free Stock & ETF Comparisons

Compare Rocket Lab's launch cadence and Neutron development against Lockheed Martin's multi-year defense programs and dividend.

Compare Rocket Lab's growth-stage launch and space systems business against RTX's engines, missiles, and commercial aftermarket scale.

Compare Rocket Lab's vertically integrated space business against Kratos' unmanned systems, targets, and defense electronics.

Compare MARA's bitcoin-heavy balance sheet and mining scale against IREN's shift toward contracted AI compute revenue.

Compare IREN's owned-site development pipeline against TeraWulf's nuclear-adjacent power position as both convert capacity to AI hosting.

Compare Micron's memory cycle leverage and HBM position against Seagate's high-capacity drive demand from data center storage buildouts.

Compare Arista's high-margin data center switching and software model against Coherent's optical component manufacturing and transceiver exposure.

Compare Ciena's coherent optical systems and carrier relationships against Lumentum's component and laser manufacturing supplying the same buildouts.

Compare Arista's intra-data-center Ethernet switching against Ciena's long-haul and metro optical transport connecting sites.

Compare Arista's switching platform scale against Credo's smaller but faster-growing high-speed connectivity chips and active cables.

Compare Coherent's broad optical and materials manufacturing against Astera Labs' fabless connectivity chips built for AI rack architectures.

Compare Novo Nordisk's commercialized obesity and diabetes franchise against Viking Therapeutics' pre-revenue clinical pipeline.

Compare Viking's binary clinical outcomes against Hims & Hers' consumer telehealth subscription model built on top of existing therapies.

Compare Hims & Hers' direct-to-consumer growth and platform risk against Amgen's diversified biologics portfolio and dividend.

Compare Novo Nordisk's GLP-1-driven growth and concentration risk against Amgen's broader portfolio and income profile.

Compare Chipotle's mature restaurant-level margins and throughput against Sweetgreen's smaller footprint and path to profitability.

Compare Chipotle's company-owned store economics against Restaurant Brands' asset-light franchise royalties and dividend.

Compare Chipotle's digital-led fast casual expansion against Texas Roadhouse's traffic-driven casual dining model.

Compare Airbnb's high-margin marketplace and regulatory exposure against Marriott's franchised brand portfolio and loyalty programme.

Compare Nu's deposit-funded lending growth across Latin America against Robinhood's transaction and interest revenue from US retail traders.

Compare SoFi's bank charter and lending economics against Toast's vertical software and payment volume growth in restaurants.

Compare Toast's restaurant platform economics against Nu's scaled digital banking franchise and credit cycle exposure.

Compare SoFi's member growth and lending mix against Schwab's vast custody asset base and interest-rate-sensitive earnings.

Compare Nu's rapid customer acquisition across Latin America against Schwab's entrenched advisor and retail custody scale.

Compare CrowdStrike's module-expanding endpoint platform against Tenable's vulnerability and exposure management niche.

Compare Fortinet's hardware-anchored profitability against SentinelOne's faster growth and continuing path to consistent earnings.

Compare SentinelOne's autonomous endpoint protection against Okta's identity platform and enterprise switching costs.

Compare Palo Alto's multi-product platformization strategy against Okta's focused identity and access management franchise.

Compare SentinelOne's endpoint detection growth against Tenable's slower-growing but steadier exposure management business.

Compare Snowflake's usage-driven data platform revenue against GitLab's per-seat DevOps subscription model.

Compare Caterpillar's construction and mining equipment cyclicality against Honeywell's aerospace, automation, and building technologies mix.

Compare United Rentals' fleet utilization and rental rate economics against Caterpillar's manufacturing margins and dealer network.

Compare Caterpillar's capital equipment cycle against Emerson's automation, software, and recurring service revenue.

Compare Bank of America's national deposit franchise and trading operations against U.S. Bancorp's payments and fee-heavy regional model.

Compare Bank of America's scale and diversification against Truist's regional footprint, merger integration, and yield.

Compare Progressive's data-driven personal auto pricing against AIG's commercial and specialty lines after years of restructuring.

Compare Allstate's auto and home underwriting margins against MetLife's group benefits and interest-rate-sensitive life business.

Compare Digital Realty's capital-intensive data center development against American Tower's long-term tower leases and escalators.

Compare Equinix's dense interconnection ecosystem against American Tower's contracted tower revenue and international exposure.

Compare Ford's F-Series profit engine and EV losses against Stellantis' brand breadth, inventory issues, and deep valuation.

Compare Tesla's software, energy, and autonomy optionality against Stellantis' low-multiple volume manufacturing.

Compare Ford's North American truck economics against BYD's battery integration, cost leadership, and export expansion.

Compare Lennar's high-volume, incentive-driven model against Toll Brothers' affluent buyers who are less dependent on mortgage rates.

Compare D.R. Horton's entry-level volume and rate sensitivity against Toll Brothers' higher-priced, lower-leverage buyer profile.

Compare PulteGroup's spread across entry-level, move-up, and active adult buyers against Toll Brothers' concentrated luxury strategy.

Compare Medtronic's breadth across cardiac, diabetes, and surgical against Zimmer Biomet's concentrated hip and knee franchise.

Compare Boston Scientific's electrophysiology-led growth across many franchises against Insulet's single-product Omnipod concentration.

Compare Edwards' structural heart concentration and competitive risk against Abbott's devices, diagnostics, and nutrition breadth.